The Patent Finder

Indazole Inhibitors of the WNT Signal Pathway and Therapeutic Uses Thereof (2013)

Biosplice Therapeutics, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 6 of these applications claim priority to application 61/620,107, filed Apr 4, 2012. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 8,664,241Indazole Inhibitors of the WNT Signal Pathway and Therapeutic Uses Thereof
In force
 · High confidence
UsedRemaining
Biosplice Therapeutics, Inc.In forceHigh confidence
US 8,673,936Indazole Inhibitors of the WNT Signal Pathway and Therapeutic Uses Thereof
In force
 · High confidence
Biosplice Therapeutics, Inc.In forceHigh confidence
US 9,199,991Indazole Inhibitors of the WNT Signal Pathway and Therapeutic Uses Thereof
In force
 · High confidence
Biosplice Therapeutics, Inc.In forceHigh confidence
US 10,407,425Indazole Inhibitors of the WNT Signal Pathway and Therapeutic Uses Thereof
In force
 · High confidence
Biosplice Therapeutics, Inc.In forceHigh confidence
US 10,947,228Indazole Inhibitors of the WNT Signal Pathway and Therapeutic Uses Thereof
In force
 · High confidence
Tenarx, Inc.In forceHigh confidence
US 11,697,649Indazole Inhibitors of the WNT Signal Pathway and Therapeutic Uses Thereof
In force
 · High confidence
Tenarx, Inc.In forceHigh confidence
US 8,987,298Indazole Inhibitors of the WNT Signal Pathway and Therapeutic Uses Thereof
In force
 · High confidence
Biosplice Therapeutics, Inc.In forceHigh confidence
US 9,994,563Indazole Inhibitors of the WNT Signal Pathway and Therapeutic Uses Thereof
In force
 · High confidence
Biosplice Therapeutics, Inc.In forceHigh confidence
Application 18/315,047Indazole Inhibitors of the WNT Signal Pathway and Therapeutic Uses Thereof
Abandoned
Abandoned Jun 6, 2025
Biosplice Therapeutics, Inc.AbandonedAbandoned Jun 6, 2025
Application 19/231,090Indazole Inhibitors of the WNT Signal Pathway and Therapeutic Uses Thereof
Pending
Not granted
BioSplice Therapeutics, Inc.PendingNot granted
10 of 10 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
6 of these are in force and held by Biosplice Therapeutics, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited